Cargando…
Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway
INTRODUCTION: Interleukin-1 receptor-associated kinase 1 (IRAK1) was shown to contribute to a variety of cancer-related processes. However, the function of IRAK1 in hepatocellular carcinoma (HCC) pathogenesis has not been investigated in detail. METHODS: IRAK1 expression in HCC was examined by immun...
Autores principales: | Chen, Wei, Wei, Tao, Chen, Yinghua, Yang, Lan, Wu, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751837/ https://www.ncbi.nlm.nih.gov/pubmed/33363384 http://dx.doi.org/10.2147/OTT.S260793 |
Ejemplares similares
-
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
por: Bennett, Joshua, et al.
Publicado: (2022) -
IRAK-M suppresses the activation of microglial NLRP3 inflammasome and GSDMD-mediated pyroptosis through inhibiting IRAK1 phosphorylation during experimental autoimmune encephalomyelitis
por: Wang, Yuanyuan, et al.
Publicado: (2023) -
PINK1 positively regulates IL-1β-mediated signaling through Tollip and IRAK1 modulation
por: Lee, Hyun Jung, et al.
Publicado: (2012) -
IRAK1 mediates TLR4-induced ABCA1 downregulation and lipid accumulation in VSMCs
por: Guo, L, et al.
Publicado: (2015) -
Helical assembly in the MyD88:IRAK4:IRAK2 complex in TLR/IL-1R signaling
por: Lin, Su-Chang, et al.
Publicado: (2010)